A Phase 1b Study of QX1206 in T2DM Patients With NAFLD (NCT06694935)
A Phase 1b Study of QX1206 in Type 2 Diabetes Mellitus (T2DM) Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
🩺 Plain-English Summary (8th-Grade Level)
This is an open label phase 1b trial of QX1206 in patients with T2DM and with NAFLD. Laboratory tests and other measurements will be assessed prior to the first dose of study treatment and throughout the study to determine the recommended phase 2 dose. In addition, the preliminary effects of QX1206 on antidiabetic activity and other metabolic parameters will also be evaluated.
Who can join: Review the eligibility criteria below.
Location: Centricity Research Toronto LMC. — Toronto
Age range: 18 Years to 64 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Centricity Research Toronto LMC. — Toronto,
📞 Contact the Study Coordinator
Phone: (617) 649-1157
Email: T2DM-QX1206-1_Study@1globe-usa.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type 2 Diabetes Mellitus (T2DM)
- Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations — Greenfield, Massachusetts
- A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Birmingham, Alabama
- Effect of Rosmarinus Officinalis Extract on Oxidative Stress and Inflammatory Biomarkers in Patients With Type 2 Diabetes (T2DM) — Zacatecas City, Zacatecas
- BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes — Mexico City, Cuauhtémoc
- Cohort Study of Metabolic Disease and Hypertension — Mexico City, Mexico City
- HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide — Nashville, Tennessee
Explore by condition: All Type 2 Diabetes Mellitus (T2DM) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.